Detalhe da pesquisa
1.
One-year clinical outcomes of MR-guided stereotactic body radiation therapy with rectal spacer for patients with localized prostate cancer.
World J Urol
; 42(1): 97, 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38393414
2.
Prostate diffusion-weighted imaging (DWI) in MR-guided radiotherapy: Reproducibility assessment on 1.5 T MR-Linac and 1.5 T MR-simulator.
Magn Reson Imaging
; 111: 47-56, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513789
3.
Analysis of online plan adaptation for 1.5T magnetic resonance-guided stereotactic body radiotherapy (MRgSBRT) of prostate cancer.
J Cancer Res Clin Oncol
; 149(2): 841-850, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35199189
4.
A Prospective Study of Stereotactic Body Radiotherapy (SBRT) with Concomitant Whole-Pelvic Radiotherapy (WPRT) for High-Risk Localized Prostate Cancer Patients Using 1.5 Tesla Magnetic Resonance Guidance: The Preliminary Clinical Outcome.
Cancers (Basel)
; 14(14)2022 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35884553
5.
1.5T Magnetic Resonance-Guided Stereotactic Body Radiotherapy for Localized Prostate Cancer: Preliminary Clinical Results of Clinician- and Patient-Reported Outcomes.
Cancers (Basel)
; 13(19)2021 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638348